The BIO International Convention attracts ~15,000+ biotechnology and pharma leaders for one week of intensive networking to discover new opportunities and promising partnerships. BIO brings together a wide spectrum of life science and application innovators in drug discovery, biomanufacturing, genomics, nanotechnology, and cell therapy.
Panel Session
June 24, 4:15-5:15pm
“The Therapeutic Modality Puzzle in Oncology: One Size Fits All or Fit to Purpose?”
– Moderator: Jeff Bockman
Panelists:
– Maurits Geerlings, MD, President and CEO, Nanocell
– Hans-Peter Gerber, PhD, CSO, Sutro Biopharma
– Axel Hoos, MD, PhD, CEO and Founder, Stealth Biotech
– Johanna K. Kaufmann, PhD, CSO, Deck Bio
– Adina Pelusio, Chief Development Officer, KaliVir Immunotherapeutics
Connect with us during BIO 2026 in San Diego, in the partnering portal, or by emailing us at contact@lumanity.com